| Affiliation with other organizations: |
BHI has been involved in advising and the formulation of national and international cervical cancer screening guidelines in collaboration with the World Health Organization (WHO), the Pan American Health Organization (PAHO), the Centers for Disease Control (CDC), and several Ministries of Health in Latin America and the Caribbean. |
| Publications: |
Comparison of depth of necrosis using cryotherapy by gas and number of freeze cycles, Oct 2016. Adherence to recommended follow-up care after high-grade cytology in El Salvador, January 2016. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador, Aug 2016. Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions, Spring 2017. Factors affecting attendance to cervical cancer screening among women in the Paracentral region of El Salvador: A nested study within the CAPE HPV screening program, July 2016. Acceptability of self-collected vs. provider-collected sampling for Human Papillomavirus DNA testing among women in rural El Salvador, August 2016. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador, August 2015. Introducing a High-Risk HPV DNA Test into a public sector screening program in El Salvador, August 2015. Scale-up of an Human Implementation Program in El Salvador, September 2016. Cervical Cancer Prevention in El Salvador (CAPE) - A Demontration Project that has led to a change in Secondary Prevention Paradigm in a Low and Middle-Income Country, October 2016. A Non-Gas-Based Cryotherapy System for the Treatment of Cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing, August 2016. Cervical pre-cancer treatment in low and middle-income countries: a technology overview, August 2016. |
Statements or documents submitted
to the Commission on the Status of Women:
|
Basic Health International (BHI) is a recognized 501(c)3 non-profit organization whose mission is to eradicate cervical cancer globally. BHI has been working on the ground for more than two decades. BHI utilizes its expertise in women’s health to provide clinical training, research and public policy guidance in the field of cervical cancer screening and treatment, particularly for women in low-resource settings. BHI has offices in New York City, NY; Pittsburgh, PA; and San Salvador, El Salvador. BHI works on multiple levels to eradicate cervical cancer: • Research • Medical training • Patient care • Policy guidance Research: BHI wants to prevent cervical cancer. The goal is to make prevention – both primary and secondary – more accessible to women around the world. BHI has published more than 30 articles in national and international peer-reviewed journals to help disseminate findings. Working as a subcontractor of the Cleveland Clinic Lerner School of Medicine, BHI has received funding from the National Institute of Health (NIH), and several private foundations to perform field research. Medical Training: BHI trains health professionals in low-tech, low-cost screening and treatment methods appropriate for use in low-resource settings. To date, BHI has trained over 1,500 clinicians who use these skills throughout El Salvador, Colombia, Guatemala, Peru, Haiti, and the Dominican Republic, and Mexico. Patient Care: BHI offers free cervical pre-cancer screening and treatment and provides arrangements for transportation, food, housing and treatment for all women identified with cervical cancer. To date, BHI with the support of their partners has screened over 45,000 women and has treated over 4,000 women. |
Quadrennial report due? Read more on our updated page.
Questions on applications, reports, or other inquiries
Applying for ECOSOC Consultative Status?
Obtaining a UN Grounds Pass
Registering for a UN Conference?